Self-injected epinephrine is used to treat anaphylaxis, a severe and potentially fatal allergic reaction that can cause airways to swell shut, blood pressure to plummet, or both within minutes of exposure to a trigger. It is the only first-line treatment for anaphylaxis, and auto-injectors like EpiPen are designed so that people at risk can carry the drug and administer it themselves before emergency help arrives.
What Anaphylaxis Looks Like
Anaphylaxis is not the same as a mild allergic reaction. It involves rapid, serious dysfunction in more than one body system at the same time. The most widely used diagnostic criteria describe three scenarios where anaphylaxis is highly likely: skin or mucosal symptoms (hives, flushing, swollen lips or tongue) combined with breathing problems or a dangerous drop in blood pressure; two or more organ systems reacting after exposure to a likely allergen; or a sudden blood pressure drop after contact with a known allergen.
In practical terms, that can look like sudden full-body hives with wheezing and dizziness, throat tightness with vomiting and a rapid pulse, or feeling faint seconds after a bee sting. Symptoms typically appear within minutes, though they can take up to several hours. Speed matters: the faster you recognize anaphylaxis, the sooner epinephrine can work.
Common Triggers by Age
The allergens most likely to cause anaphylaxis shift dramatically between childhood and adulthood. In children, food is the dominant trigger, responsible for about 70% of severe reactions. The most common culprits are peanut, cow’s milk, cashew, hen’s egg, and hazelnut. Insect venom accounts for roughly 16% of childhood cases, and medications about 5%.
In adults, the pattern reverses. Insect venom (bee stings, wasp stings) causes about half of all anaphylaxis cases. Medications are the second most common trigger at 23%, followed by food at 21%. Among adults, the leading food triggers are crustaceans, molluscs, and wheat rather than the nut and dairy allergens that dominate in childhood. Anyone who has experienced anaphylaxis from any of these triggers is typically prescribed a self-injectable epinephrine device to carry at all times.
How Epinephrine Reverses the Reaction
Epinephrine works on two fronts simultaneously. It tightens blood vessels, which raises blood pressure back toward a safe level and reduces the swelling that can close off airways. At the same time, it relaxes the smooth muscle in the lungs, opening constricted airways so breathing becomes easier. It also increases heart rate and the force of each heartbeat, helping the cardiovascular system recover from shock. No other single drug addresses all of these problems at once, which is why epinephrine remains the cornerstone of anaphylaxis treatment.
Dosage and Who Carries It
Auto-injectors come in two standard doses. Adults and children weighing 30 kg (about 66 pounds) or more use the 0.3 mg device. Children between 15 and 30 kg (roughly 33 to 66 pounds) use the 0.15 mg device. Safety and effectiveness have not been established for children under 15 kg, though in a life-threatening emergency the lower-dose injector is still generally used because the risk of untreated anaphylaxis far outweighs the risks of the drug. There are no absolute contraindications to using epinephrine during anaphylaxis.
Where and How to Inject
The correct injection site is the outer mid-thigh, into the large muscle there. This location provides the fastest and most reliable absorption into the bloodstream. Injecting into the thigh muscle produces an initial peak concentration in the blood at roughly 5 minutes, with most patients seeing the drug reach effective levels within 10 minutes. By contrast, injecting just under the skin (subcutaneously) delays that first peak to about 15 minutes.
You can inject through clothing if needed. The device is pressed firmly against the outer thigh and held in place for several seconds to deliver the full dose. After injection, you should call emergency services even if symptoms improve, because the effects of a single dose can wear off before the allergic reaction fully resolves. A second dose can be given if symptoms return or don’t improve within 5 to 15 minutes.
Why Observation After Use Matters
Even after a successful injection, a second wave of symptoms called a biphasic reaction can occur. In one study of 202 patients treated for anaphylaxis, about 9% experienced a biphasic reaction. Of those, 3% had reactions severe enough to meet the full criteria for anaphylaxis again, and 1% had dangerous changes in vital signs. Current international guidelines recommend at least one hour of medical observation after a mild episode and at least six hours for severe cases, though research suggests that some biphasic reactions occur beyond that six-hour window.
Storing Your Auto-Injector
Epinephrine degrades when exposed to extreme temperatures or light. Manufacturers recommend storing auto-injectors at room temperature, between 20°C and 25°C (68°F to 77°F), with brief excursions acceptable in the 15°C to 30°C range (59°F to 86°F). That means you should avoid leaving the device in a hot car, a freezing glove compartment, or direct sunlight. A discolored or cloudy solution is a sign of degradation. Check the expiration date regularly and replace expired devices, since potency declines over time even under ideal conditions.
Training and Preparedness
Having an auto-injector is only useful if you and the people around you know how to use it. Practice guidelines emphasize that prescribing the device is not enough on its own. Patients and caregivers need hands-on training with a practice device, a clear understanding of which symptoms should prompt injection, and a plan for whether and when to call emergency services afterward. If epinephrine is used promptly and produces a complete, lasting improvement, immediate activation of emergency services may not always be required, but medical follow-up is still recommended because of the risk of biphasic reactions.
People taking certain heart or blood pressure medications, particularly beta-blockers, sometimes worry that those drugs could interfere with epinephrine or worsen anaphylaxis. Current guidelines indicate that for most patients, the risk of stopping those medications outweighs the risk of a potentially more complicated allergic reaction. This is especially relevant for people with insect sting allergies, who may need their heart medication more than they need to optimize their theoretical response to epinephrine.